ADMA Biologic’s Plasma Collection Facility Receives GHA Certification for the Sale of Source Plasma in Europe ADMA Biologics, Inc. , a specialty immune globulin company that develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases, today announced that its subsidiary, ADMA BioCenters, received a two-year certification from the German Health Authorities .
June 18, 2013 - Business Wire via Yahoo! Finance